DeepMed Research

AMOREPACIFIC CORPORATION

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: -

Established: 2006-01-01

Employees: -

Market Cap: -

Website: http://eng.amorepacific.co.kr/

Clinical Trials

Anti-pollution Effects of AP Green Tea Extracts

Not Applicable

Completed

Conditions: Respiratory Conditions Due to Unspecified External Agent

Interventions: Dietary Supplement: AP green tea extracts

First Posted Date: 2020-04-09

Last Posted Date: 2021-06-16

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 40

Registration Number: NCT04340375

Locations: 🇰🇷
Hanyang University Seoul Hospital, Seoul, Korea, Republic of

CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis

Phase 3

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: PAC-14028 cream Vehicle
Drug: PAC-14028 cream 1.0%

First Posted Date: 2016-11-16

Last Posted Date: 2018-11-20

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 240

Registration Number: NCT02965118

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis

Phase 2

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: PAC-14028 cream 0.1%
Drug: PAC-14028 cream vehicle
Drug: PAC-14028 cream 0.3%
Drug: PAC-14028 cream 1.0%

First Posted Date: 2016-05-02

Last Posted Date: 2016-09-20

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 192

Registration Number: NCT02757729

Locations: 🇰🇷
Chung-ang University Hospital, Seoul, Korea, Republic of

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis

Phase 2

Completed

Conditions: Seborrheic Dermatitis

Interventions: Drug: PAC-14028 cream vehicle
Drug: PAC-14028 cream 1.0%
Drug: PAC-14028 cream 0.3%

First Posted Date: 2016-04-25

Last Posted Date: 2016-04-25

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 75

Registration Number: NCT02749383

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

Phase 1

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: PAC-14028 Cream Vehicle
Drug: PAC-14028 Cream 0.3%
Drug: PAC-14028 Cream 1.0%
Drug: PAC-14028 Cream 0.1%

First Posted Date: 2016-04-22

Last Posted Date: 2018-11-20

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 56

Registration Number: NCT02748993

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷
Konkuk University Hospital, Seoul, Korea, Republic of
🇰🇷
Chung-ang University Hospital, Seoul, Korea, Republic of

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea

Phase 2

Completed

Conditions: Rosacea

Interventions: Drug: PAC-14028 cream vehicle
Drug: PAC-14028 cream 0.1%
Drug: PAC-14028 cream 0.3%
Drug: PAC-14028 cream 1.0%

First Posted Date: 2015-10-21

Last Posted Date: 2016-09-20

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 216

Registration Number: NCT02583009

Locations: 🇰🇷
Korea University Ansan Hospital, Ansan si, Gyeonggi-do, Korea, Republic of

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis

Phase 2

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: Elidel cream 1%
Drug: PAC-14028 cream vehicle
Drug: PAC-14028 cream 1.0%

First Posted Date: 2015-10-21

Last Posted Date: 2015-10-21

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 74

Registration Number: NCT02583022

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus

Phase 2

Completed

Conditions: Skin Pruritus

Interventions: Drug: PAC-14028 cream 0.1%
Drug: PAC-14028 cream 0.3%
Drug: PAC-14028 cream 1.0%
Drug: PAC-14028 cream vehicle

First Posted Date: 2015-10-01

Last Posted Date: 2016-07-15

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 296

Registration Number: NCT02565134

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PAC-14028
Other: Vehicle

First Posted Date: 2014-12-05

Last Posted Date: 2016-04-22

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 24

Registration Number: NCT02309008

Locations: 🇰🇷
Seoul National University Hospital Clinical Trials Center, Seoul, Korea, Republic of

Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients

Phase 2

Completed

Conditions: Erythematotelangiectatic Rosacea
Papulopustular Rosacea

Interventions: Drug: PAC-14028 cream 1%
Other: Vehicle
Drug: Rozex gel 0.75%

First Posted Date: 2014-02-03

Last Posted Date: 2014-02-03

Lead Sponsor: Amorepacific Corporation

Target Recruit Count: 80

Registration Number: NCT02052999

Locations: 🇰🇷
Chung-Ang University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy